Obafemi Awolowo University Teaching Hospital
Clinical trials sponsored by Obafemi Awolowo University Teaching Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Cholesterol drug could boost TB treatment – new study tests best dose Results expected Mar 2027 (estimated)
-
Could a common statin help beat tuberculosis?
Disease control Recruiting nowThis study tests whether adding atorvastatin, a widely used cholesterol-lowering drug, to standard tuberculosis (TB) antibiotics can help clear the infection faster and reduce lung damage. About 440 adults with pulmonary TB will receive either standard treatment alone or with dif…
Phase 2 • Sponsor: Obafemi Awolowo University Teaching Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Cholesterol drug could boost TB treatment – new study tests best dose
Knowledge-focused Recruiting nowThis study looks at how the cholesterol-lowering drug atorvastatin behaves in the body when taken alongside standard tuberculosis (TB) medicines. Researchers will measure drug levels in 80 adults with pulmonary TB to find the best dose of atorvastatin that could help treat TB mor…
Phase 2 • Sponsor: Obafemi Awolowo University Teaching Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC